Mutual Fund Ownership
Ownership as on: Sat, 9 Nov, 2024

UTI Flexi Cap Fund Regular Plan Growth

2/5
Equity
Amount Invested (Cr.)368.46
% of AUM1.42%

UTI Nifty Midcap 150 Quality 50 Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)3.45
% of AUM1.40%

UTI Mid Cap Fund Regular Plan Growth

2/5
Equity
Amount Invested (Cr.)121.33
% of AUM1.02%

UTI Small Cap Fund Regular Growth

2/5
Equity
Amount Invested (Cr.)42.33
% of AUM0.93%

UTI Balanced Advantage Fund Regular Growth

NA
Hybrid
Amount Invested (Cr.)15.12
% of AUM0.51%

FAQs about Dr. Lal Pathlabs share price

Dr. Lal Pathlabs is trading at 3060.00 as on Fri Nov 08 2024 09:58:47. This is -0.36% lower as compared to its previous closing price of 3071.10.

The market capitalization of Dr. Lal Pathlabs is 25590.19 Cr as on Fri Nov 08 2024 09:58:47.

The average broker rating on Dr. Lal Pathlabs is Hold. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 7 analysts have given a buy rating
  • 5 analysts have given a hold rating
  • 4 analysts have given a sell rating
  • 3 analysts have given a strong sell rating

The 52 wk high for Dr. Lal Pathlabs is 3645.00 whereas the 52 wk low is 1943.20

Dr. Lal Pathlabs can be analyzed on the following key metrics -

  • TTM P/E: 68.46
  • Sector P/E: 28.40
  • Dividend Yield: 0.98%
  • D/E ratio: 0.10

Dr. Lal Pathlabs reported a net profit of 357.70 Cr in 2024.

Recommended For You
Trending Stocks
2,979.25+89.20(3.09%)
3,186.35+66.40(2.13%)
1,682.50+31.40(1.90%)
2,769.25-74.20 (-2.61%)
147.55-3.35 (-2.22%)
HomeMarketsPremiumInstant LoanMint Shorts